文献速递骨软组织肉瘤与黑色素瘤

表观遗传与转录程序定义骨肉瘤亚型并揭示可靶向脆弱性

Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities.
PubMed 文献 · Cancer Discov · 2026-01-01

研究通过染色质可及性分析在基因组复杂的骨肉瘤中鉴定出「早期成骨细胞来源」与「晚期成骨细胞来源」两种细胞状态,并定义其核心调控回路;多组学单细胞分析显示两种状态可在同一肿瘤中共存,患者来源异种移植模型显示药物反应因细胞状态而异。

要点

  • 骨肉瘤存在两种表观遗传定义的细胞状态,与正常骨发育阶段相关。
  • 两种细胞状态可在同一肿瘤内共存,并对应不同的核心转录调控回路。
  • 患者来源异种移植模型显示药物反应依赖细胞状态,提示联合治疗策略。

核心结论

  • 骨肉瘤可按表观遗传和转录程序分为两种细胞状态,且这两种状态具有可靶向的药物反应差异。

研究设计与样本

  • 基于染色质可及性分析鉴定骨肉瘤细胞状态并定义核心调控回路,结合多组学单细胞分析和患者来源异种移植模型验证。

主要发现

  • 鉴定出「早期成骨细胞来源」状态,以早期骨发育相关转录因子上调为特征。
  • 鉴定出「晚期成骨细胞来源」状态,以晚期骨发育相关基因上调为特征。
  • 多组学单细胞分析显示两种细胞状态可在单一肿瘤中共存。
  • 患者来源异种移植模型显示药物反应因细胞状态不同而存在差异。
  • 表观遗传定义的细胞状态可在患者样本中识别,并与生存相关。

临床怎么用

  • 提示可依据骨肉瘤细胞状态设计新的联合治疗策略。
  • 强调在基因组高度复杂的癌症中定义表观遗传亚型的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Osteosarcoma is a genomically complex tumor characterized by widespread structural rearrangements. This complexity has limited the development of therapeutic strategies informed by molecular mechanisms of oncogenesis. We hypothesized that epigenetic mechanisms could drive distinct subtypes of osteosarcoma. Through analysis of chromatin accessibility, we identified an "early osteoblast-derived" cell state, characterized by upregulation of transcription factors associated with early bone development, and a "late osteoblast-derived" state, characterized by upregulation of genes involved in late bone development. We then defined core regulatory circuitries governing the underlying gene expression programs in these two cell states. Multiomic single-cell analysis indicates that these cell states coexist in a single tumor. Finally, using a panel of patient-derived xenograft models, we identified differential drug responses dependent on these cellular states. These findings create opportunities for developing new combination therapy strategies for osteosarcoma treatment and underscore the value of defining epigenetic subtypes in highly genomically complex cancers. SIGNIFICANCE: This study identifies two distinct cellular states in osteosarcoma, driven by specific transcription factor circuitries linked to normal bone development. These epigenetically defined states demonstrate differential drug responses, are identifiable in patient samples, and are correlated with survival.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. López-Fuentes E, Clugston AS, Lee AG, et al. Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities. Cancer Discov. 2026. PMID: 41037662. doi:10.1158/2159-8290.CD-25-0237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。